Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

38 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase III randomized trial comparing moderate-dose cisplatin to combined cisplatin and carboplatin in addition to mitomycin and ifosfamide in patients with stage IV non-small-cell lung cancer.
Sculier JP, Lafitte JJ, Paesmans M, Thiriaux J, Alexopoulos CG, Baumöhl J, Schmerber J, Koumakis G, Florin MC, Zacharias C, Berghmans T, Mommen P, Ninane V, Klastersky J. Sculier JP, et al. Among authors: schmerber j. Br J Cancer. 2000 Nov;83(9):1128-35. doi: 10.1054/bjoc.2000.1413. Br J Cancer. 2000. PMID: 11027424 Free PMC article. Clinical Trial.
A four-drug combination chemotherapy with cisplatin, mitomycin, vindesine and 5 fluorouracile: a regimen associated with major toxicity in patients with advanced non-small cell lung cancer.
Klastersky J, Sculier JP, Ries F, Dabouis G, Libert P, Schmerber J, Thiriaux J, Berchier MC, Bureau G, Van Cutsem O, et al. Klastersky J, et al. Among authors: schmerber j. Lung Cancer. 1994 Dec;11(5-6):373-84. doi: 10.1016/0169-5002(94)92166-0. Lung Cancer. 1994. PMID: 7704494 Clinical Trial.
Prognostic factors for response to chemotherapy containing platinum derivatives in patients with unresectable non-small cell lung cancer. (NSCLC).
Borges M, Sculier JP, Paesmans M, Richez M, Bureau G, Dabouis G, Lecomte J, Michel J, Van Cutsem O, Schmerber J, Giner V, Berchier MC, Sergysels R, Mommen P, Klastersky J. Borges M, et al. Among authors: schmerber j. Lung Cancer. 1996 Dec;16(1):21-33. doi: 10.1016/s0169-5002(96)00609-5. Lung Cancer. 1996. PMID: 9017582
A four-drug combination chemotherapy with cisplatin, mitomycin, vindesine and 5-fluorouracil. A regimen associated with major toxicity in patients with advanced non-small lung cancer. European Lung Cancer Working Party.
Klastersky J, Sculier JP, Ries F, Dabouis G, Libert P, Schmerber J, Thiriaux J, Berchier MC, Bureau G, Van Cutsem O, et al. Klastersky J, et al. Among authors: schmerber j. Ann Oncol. 1994 Sep;5(7):641-3. doi: 10.1093/oxfordjournals.annonc.a058937. Ann Oncol. 1994. PMID: 7993841 Free article. Clinical Trial.
[Thymoma and pregnancy. Apropos of a case].
Thomas D, Vokaer A, Devriendt J, Ketelbant P, De Francquen P, Schmerber J, Wudka G. Thomas D, et al. Among authors: schmerber j. J Gynecol Obstet Biol Reprod (Paris). 1986;15(3):293-8. J Gynecol Obstet Biol Reprod (Paris). 1986. PMID: 3734343 French.
38 results